secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marker Therapeutics, Inc. (MRKR)
CIK:        0001094038
Form:       8-K
Filed at:   2025-06-09T23:59:59+00:00
Accession:  0001104659-25-057836
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marker Therapeutics stockholders elect directors, approve say-on-pay, ratify auditor at 2025 annual meeting
--------------------------------------------------------------------------------

- Four director nominees elected: Eansor (4.1M for), Elms (4.1M), Knobil (4.1M), Vera (4.1M); broker non-votes 2.8M.
- Advisory vote on named executive officer compensation passed: 4.45M for, 343K against, 13.9K abstain.
- Ratification of Marcum LLP as independent auditor for FY2025: 7.49M for, 80.8K against, 53.9K abstain.
- Total shares outstanding 11.3M; 67.43% quorum (7.63M shares present or proxy).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1094038/000110465925057836/0001104659-25-057836-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1094038/000110465925057836/tm2517533d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-057836

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer